Global Meningococcal Vaccine Market Analysis and Forecast 2024-2030

Global Meningococcal Vaccine Market Analysis and Forecast 2024-2030


Summary

Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.

According to APO Research, The global Meningococcal Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Meningococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Meningococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Meningococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Meningococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Meningococcal Vaccine include Novartis, GSK, Merck, CSL, Baxter, JN International Medical Corporation, Serum Institute of India, Bio-Med and China National Biotec Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Meningococcal Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Meningococcal Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Meningococcal Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Meningococcal Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Meningococcal Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Meningococcal Vaccine sales, projected growth trends, production technology, application and end-user industry.

Meningococcal Vaccine segment by Company

Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei
Meningococcal Vaccine segment by Type

Meningtits A
Polysaccharide Meningtitis AC
Meningitis ACYW
Meningococcal Vaccine segment by Application

6 Months-15Year
over 3 Year
over 2 Year
over 3 Months
Meningococcal Vaccine segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meningococcal Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Meningococcal Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meningococcal Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Meningococcal Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Meningococcal Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Meningococcal Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Meningococcal Vaccine Market by Type
1.2.1 Global Meningococcal Vaccine Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Meningtits A
1.2.3 Polysaccharide Meningtitis AC
1.2.4 Meningitis ACYW
1.3 Meningococcal Vaccine Market by Application
1.3.1 Global Meningococcal Vaccine Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 6 Months-15Year
1.3.3 over 3 Year
1.3.4 over 2 Year
1.3.5 over 3 Months
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Meningococcal Vaccine Market Dynamics
2.1 Meningococcal Vaccine Industry Trends
2.2 Meningococcal Vaccine Industry Drivers
2.3 Meningococcal Vaccine Industry Opportunities and Challenges
2.4 Meningococcal Vaccine Industry Restraints
3 Global Market Growth Prospects
3.1 Global Meningococcal Vaccine Revenue Estimates and Forecasts (2019-2030)
3.2 Global Meningococcal Vaccine Revenue by Region
3.2.1 Global Meningococcal Vaccine Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Meningococcal Vaccine Revenue by Region (2019-2024)
3.2.3 Global Meningococcal Vaccine Revenue by Region (2025-2030)
3.2.4 Global Meningococcal Vaccine Revenue Market Share by Region (2019-2030)
3.3 Global Meningococcal Vaccine Sales Estimates and Forecasts 2019-2030
3.4 Global Meningococcal Vaccine Sales by Region
3.4.1 Global Meningococcal Vaccine Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Meningococcal Vaccine Sales by Region (2019-2024)
3.4.3 Global Meningococcal Vaccine Sales by Region (2025-2030)
3.4.4 Global Meningococcal Vaccine Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Meningococcal Vaccine Revenue by Manufacturers
4.1.1 Global Meningococcal Vaccine Revenue by Manufacturers (2019-2024)
4.1.2 Global Meningococcal Vaccine Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Meningococcal Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Meningococcal Vaccine Sales by Manufacturers
4.2.1 Global Meningococcal Vaccine Sales by Manufacturers (2019-2024)
4.2.2 Global Meningococcal Vaccine Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Meningococcal Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Meningococcal Vaccine Sales Price by Manufacturers (2019-2024)
4.4 Global Meningococcal Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Meningococcal Vaccine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Meningococcal Vaccine Manufacturers, Product Type & Application
4.7 Global Meningococcal Vaccine Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Meningococcal Vaccine Market CR5 and HHI
4.8.2 2023 Meningococcal Vaccine Tier 1, Tier 2, and Tier 3
5 Meningococcal Vaccine Market by Type
5.1 Global Meningococcal Vaccine Revenue by Type
5.1.1 Global Meningococcal Vaccine Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Meningococcal Vaccine Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Meningococcal Vaccine Revenue Market Share by Type (2019-2030)
5.2 Global Meningococcal Vaccine Sales by Type
5.2.1 Global Meningococcal Vaccine Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Meningococcal Vaccine Sales by Type (2019-2030) & (10K Pcs)
5.2.3 Global Meningococcal Vaccine Sales Market Share by Type (2019-2030)
5.3 Global Meningococcal Vaccine Price by Type
6 Meningococcal Vaccine Market by Application
6.1 Global Meningococcal Vaccine Revenue by Application
6.1.1 Global Meningococcal Vaccine Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Meningococcal Vaccine Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Meningococcal Vaccine Revenue Market Share by Application (2019-2030)
6.2 Global Meningococcal Vaccine Sales by Application
6.2.1 Global Meningococcal Vaccine Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Meningococcal Vaccine Sales by Application (2019-2030) & (10K Pcs)
6.2.3 Global Meningococcal Vaccine Sales Market Share by Application (2019-2030)
6.3 Global Meningococcal Vaccine Price by Application
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Comapny Information
7.1.2 Novartis Business Overview
7.1.3 Novartis Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Novartis Meningococcal Vaccine Product Portfolio
7.1.5 Novartis Recent Developments
7.2 GSK
7.2.1 GSK Comapny Information
7.2.2 GSK Business Overview
7.2.3 GSK Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 GSK Meningococcal Vaccine Product Portfolio
7.2.5 GSK Recent Developments
7.3 Merck
7.3.1 Merck Comapny Information
7.3.2 Merck Business Overview
7.3.3 Merck Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Merck Meningococcal Vaccine Product Portfolio
7.3.5 Merck Recent Developments
7.4 CSL
7.4.1 CSL Comapny Information
7.4.2 CSL Business Overview
7.4.3 CSL Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 CSL Meningococcal Vaccine Product Portfolio
7.4.5 CSL Recent Developments
7.5 Baxter
7.5.1 Baxter Comapny Information
7.5.2 Baxter Business Overview
7.5.3 Baxter Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Baxter Meningococcal Vaccine Product Portfolio
7.5.5 Baxter Recent Developments
7.6 JN International Medical Corporation
7.6.1 JN International Medical Corporation Comapny Information
7.6.2 JN International Medical Corporation Business Overview
7.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 JN International Medical Corporation Meningococcal Vaccine Product Portfolio
7.6.5 JN International Medical Corporation Recent Developments
7.7 Serum Institute of India
7.7.1 Serum Institute of India Comapny Information
7.7.2 Serum Institute of India Business Overview
7.7.3 Serum Institute of India Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Serum Institute of India Meningococcal Vaccine Product Portfolio
7.7.5 Serum Institute of India Recent Developments
7.8 Bio-Med
7.8.1 Bio-Med Comapny Information
7.8.2 Bio-Med Business Overview
7.8.3 Bio-Med Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Bio-Med Meningococcal Vaccine Product Portfolio
7.8.5 Bio-Med Recent Developments
7.9 China National Biotec Group
7.9.1 China National Biotec Group Comapny Information
7.9.2 China National Biotec Group Business Overview
7.9.3 China National Biotec Group Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 China National Biotec Group Meningococcal Vaccine Product Portfolio
7.9.5 China National Biotec Group Recent Developments
7.10 Hualan Bio
7.10.1 Hualan Bio Comapny Information
7.10.2 Hualan Bio Business Overview
7.10.3 Hualan Bio Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Hualan Bio Meningococcal Vaccine Product Portfolio
7.10.5 Hualan Bio Recent Developments
7.11 Walvax
7.11.1 Walvax Comapny Information
7.11.2 Walvax Business Overview
7.11.3 Walvax Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Walvax Meningococcal Vaccine Product Portfolio
7.11.5 Walvax Recent Developments
7.12 Zhifei
7.12.1 Zhifei Comapny Information
7.12.2 Zhifei Business Overview
7.12.3 Zhifei Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Zhifei Meningococcal Vaccine Product Portfolio
7.12.5 Zhifei Recent Developments
8 North America
8.1 North America Meningococcal Vaccine Market Size by Type
8.1.1 North America Meningococcal Vaccine Revenue by Type (2019-2030)
8.1.2 North America Meningococcal Vaccine Sales by Type (2019-2030)
8.1.3 North America Meningococcal Vaccine Price by Type (2019-2030)
8.2 North America Meningococcal Vaccine Market Size by Application
8.2.1 North America Meningococcal Vaccine Revenue by Application (2019-2030)
8.2.2 North America Meningococcal Vaccine Sales by Application (2019-2030)
8.2.3 North America Meningococcal Vaccine Price by Application (2019-2030)
8.3 North America Meningococcal Vaccine Market Size by Country
8.3.1 North America Meningococcal Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Meningococcal Vaccine Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Meningococcal Vaccine Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 Europe
9.1 Europe Meningococcal Vaccine Market Size by Type
9.1.1 Europe Meningococcal Vaccine Revenue by Type (2019-2030)
9.1.2 Europe Meningococcal Vaccine Sales by Type (2019-2030)
9.1.3 Europe Meningococcal Vaccine Price by Type (2019-2030)
9.2 Europe Meningococcal Vaccine Market Size by Application
9.2.1 Europe Meningococcal Vaccine Revenue by Application (2019-2030)
9.2.2 Europe Meningococcal Vaccine Sales by Application (2019-2030)
9.2.3 Europe Meningococcal Vaccine Price by Application (2019-2030)
9.3 Europe Meningococcal Vaccine Market Size by Country
9.3.1 Europe Meningococcal Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Meningococcal Vaccine Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Meningococcal Vaccine Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Meningococcal Vaccine Market Size by Type
10.1.1 China Meningococcal Vaccine Revenue by Type (2019-2030)
10.1.2 China Meningococcal Vaccine Sales by Type (2019-2030)
10.1.3 China Meningococcal Vaccine Price by Type (2019-2030)
10.2 China Meningococcal Vaccine Market Size by Application
10.2.1 China Meningococcal Vaccine Revenue by Application (2019-2030)
10.2.2 China Meningococcal Vaccine Sales by Application (2019-2030)
10.2.3 China Meningococcal Vaccine Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Meningococcal Vaccine Market Size by Type
11.1.1 Asia Meningococcal Vaccine Revenue by Type (2019-2030)
11.1.2 Asia Meningococcal Vaccine Sales by Type (2019-2030)
11.1.3 Asia Meningococcal Vaccine Price by Type (2019-2030)
11.2 Asia Meningococcal Vaccine Market Size by Application
11.2.1 Asia Meningococcal Vaccine Revenue by Application (2019-2030)
11.2.2 Asia Meningococcal Vaccine Sales by Application (2019-2030)
11.2.3 Asia Meningococcal Vaccine Price by Application (2019-2030)
11.3 Asia Meningococcal Vaccine Market Size by Country
11.3.1 Asia Meningococcal Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Meningococcal Vaccine Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Meningococcal Vaccine Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Meningococcal Vaccine Market Size by Type
12.1.1 MEALA Meningococcal Vaccine Revenue by Type (2019-2030)
12.1.2 MEALA Meningococcal Vaccine Sales by Type (2019-2030)
12.1.3 MEALA Meningococcal Vaccine Price by Type (2019-2030)
12.2 MEALA Meningococcal Vaccine Market Size by Application
12.2.1 MEALA Meningococcal Vaccine Revenue by Application (2019-2030)
12.2.2 MEALA Meningococcal Vaccine Sales by Application (2019-2030)
12.2.3 MEALA Meningococcal Vaccine Price by Application (2019-2030)
12.3 MEALA Meningococcal Vaccine Market Size by Country
12.3.1 MEALA Meningococcal Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Meningococcal Vaccine Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Meningococcal Vaccine Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Meningococcal Vaccine Value Chain Analysis
13.1.1 Meningococcal Vaccine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Meningococcal Vaccine Production Mode & Process
13.2 Meningococcal Vaccine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Meningococcal Vaccine Distributors
13.2.3 Meningococcal Vaccine Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings